Vertebral Artery Type of Cervical Spondylosis
Conditions
Interventions
Control group:None
Experimental group1:Three-Dimensional Balanced spine manipulation
Experimental group2:Millimeter wave combined with Three-Dimensional Balanced spine manipulation
Sponsors
The Third Affiliated Hospital of Shandong First Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Vertebral Artery Type of Cervical Spondylosis 1.Meet the diagnostic criteria for vertebral artery type of cervical spondylosis in Western medicine; 2.Meet the diagnostic criteria for vertebral artery type of cervical spondylosis in Traditional Chinese Medicine; 3.Aged between 18 and 65 years old; 4.No gender restrictions; 5.Medical history > 1 month; .6Have not received other relevant treatments within 1 month prior to accepting the treatment plan; 7.Volunteer to participate in the clinical observation, sign the informed consent form, comply with the diagnosis and treatment plan, and cooperate with intervention observation and follow-up evaluation; Healthy Population 1.Aged between 20 and 50 years old, no gender restrictions, right-handed; 2.Without symptoms related to vertebral artery type of cervical spondylosis; 3.Able to correctly understand and clearly express their own wishes; 4.Volunteer to participate in the trial and sign the informed consent form.
Exclusion criteria
Exclusion criteria: Vertebral Artery Type of Cervical Spondylosis 1.Does not meet the above inclusion criteria; 2.Complicated with other types of cervical spondylosis, such as nerve root type, spinal cord type, or sympathetic type; 3.Vertigo caused by other reasons or diseases (e.g., vestibular disorders, cerebrovascular diseases, ocular muscle diseases, Meniere's disease); 4.Has a history of cervical spine surgery or significant cervical trauma; 5.Has only abnormal imaging findings without clinical symptoms of cervical spondylosis; 6.Has severe cardiocerebrovascular diseases, tumors, coagulation disorders, mental abnormalities, or skin damage or ulcers in the spinal region; 7.Is pregnant or lactating; 8.Has metallic foreign bodies in the body or a cardiac pacemaker (contraindications for millimeter wave therapy); 9.Has received cervical spine treatment within the past 4 weeks; 10.Has conditions unsuitable for spinal orthopedic treatment, such as cervical dislocation, fracture, bone fissure, large cervical disc herniation, protrusion, free nucleus pulposus, tuberculosis, infection, or tumors; 11.Is unable to receive treatment as required by this study, cannot be evaluated for efficacy, or has incomplete data. Healthy Population 1.Aged between 20 and 50 years old, no gender restrictions, right-handed; 2.Without symptoms related to vertebral artery type of cervical spondylosis; 3.Able to correctly understand and clearly express their own wishes; 4.Volunteers to participate in the trial and signs the informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Data of functional near-infrared spectroscopy (fNIRS) ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Expanded Scale for Cervicogenic Vertigo((ESCV );Visual Analogue Scale (VAS);Neck disability index(NDI);Self-rating Anxiety Scale(SAS); | — |
Countries
China
Contacts
Public ContactSun Guodong
The Third Affiliated Hospital of Shandong First Medical University
Outcome results
None listed